{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:23:51Z","timestamp":1777530231570,"version":"3.51.4"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T00:00:00Z","timestamp":1445817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T00:00:00Z","timestamp":1445817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver Transpl"],"published-print":{"date-parts":[[2015,11]]},"abstract":"<jats:p>There is little information on the effects of treatment with vasoconstrictors plus albumin in patients with type 2 hepatorenal syndrome (HRS), particularly those awaiting liver transplantation (LT). This study reports the effects of treatment of type 2 HRS in patients on the waiting list for LT. We included 56 patients with type 2 HRS who were awaiting LT. Out of these 56 patients, 31 were treated with terlipressin and albumin. Nineteen (61%) of these 31 patients had response to therapy, and 11 of them relapsed after treatment withdrawal. There were no differences in mortality on the waiting list between responders and nonresponders. Among the 46 (82%) patients who underwent transplantation, 15 underwent transplantation with reversal of type 2 HRS, whereas the remaining 31 underwent transplantation with type 2 HRS. There were no significant differences in serum creatinine or estimated glomerular filtration rate between the 2 cohorts of patients at 3, 6, and 12 months after transplantation. There were no significant differences regarding development of acute kidney injury, need for renal replacement therapy, frequency of chronic kidney disease 1 year after transplant, length of hospitalization, and survival. In conclusion, treatment of patients with type 2 HRS with terlipressin and albumin does not appear to have beneficial effects either in pretransplantation or in posttransplantation outcomes. <jats:italic toggle=\"yes\">Liver Transpl 21:1347\u20101354, 2015<\/jats:italic>. \u00a9 2015 AASLD.<\/jats:p>","DOI":"10.1002\/lt.24210","type":"journal-article","created":{"date-parts":[[2015,7,15]],"date-time":"2015-07-15T23:37:17Z","timestamp":1437003437000},"page":"1347-1354","source":"Crossref","is-referenced-by-count":47,"title":["Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: Effects on kidney function and transplantation outcomes"],"prefix":"10.1097","volume":"21","author":[{"given":"Ezequiel","family":"Rodriguez","sequence":"first","affiliation":[{"name":"Liver Unit, Hospital Cl\u00ednic,University of Barcelona,Barcelona,Catalunya,Spain"},{"name":"Institut d'Investigacions Biom\u00e8diques August\u2010Pi\u2010Sunyer (IDIBAPS),University of Barcelona,Barcelona,Catalonia,Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),University of Barcelona,Barcelona,Catalonia,Spain"},{"name":"Instituto Reina Sof\u00eda de Investigaci\u00f3n Nefrol\u00f3gica (IRSIN)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Henrique Pereira","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Cl\u00ednic,University of Barcelona,Barcelona,Catalunya,Spain"},{"name":"Institut d'Investigacions Biom\u00e8diques August\u2010Pi\u2010Sunyer (IDIBAPS),University of Barcelona,Barcelona,Catalonia,Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),University of Barcelona,Barcelona,Catalonia,Spain"},{"name":"Instituto Reina Sof\u00eda de Investigaci\u00f3n Nefrol\u00f3gica (IRSIN)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa","family":"Sol\u00e0","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Cl\u00ednic,University of Barcelona,Barcelona,Catalunya,Spain"},{"name":"Institut d'Investigacions Biom\u00e8diques August\u2010Pi\u2010Sunyer (IDIBAPS),University of Barcelona,Barcelona,Catalonia,Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),University of Barcelona,Barcelona,Catalonia,Spain"},{"name":"Instituto Reina Sof\u00eda de Investigaci\u00f3n Nefrol\u00f3gica (IRSIN)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Elia","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Cl\u00ednic,University of Barcelona,Barcelona,Catalunya,Spain"},{"name":"Institut d'Investigacions Biom\u00e8diques August\u2010Pi\u2010Sunyer (IDIBAPS),University of Barcelona,Barcelona,Catalonia,Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),University of Barcelona,Barcelona,Catalonia,Spain"},{"name":"Instituto Reina Sof\u00eda de Investigaci\u00f3n Nefrol\u00f3gica (IRSIN)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogelio","family":"Barreto","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Cl\u00ednic,University of Barcelona,Barcelona,Catalunya,Spain"},{"name":"Institut d'Investigacions Biom\u00e8diques August\u2010Pi\u2010Sunyer (IDIBAPS),University of Barcelona,Barcelona,Catalonia,Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),University of Barcelona,Barcelona,Catalonia,Spain"},{"name":"Instituto Reina Sof\u00eda de Investigaci\u00f3n Nefrol\u00f3gica (IRSIN)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Pose","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Cl\u00ednic,University of Barcelona,Barcelona,Catalunya,Spain"},{"name":"Institut d'Investigacions Biom\u00e8diques August\u2010Pi\u2010Sunyer (IDIBAPS),University of Barcelona,Barcelona,Catalonia,Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),University of Barcelona,Barcelona,Catalonia,Spain"},{"name":"Instituto Reina Sof\u00eda de Investigaci\u00f3n Nefrol\u00f3gica (IRSIN)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Colmenero","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Cl\u00ednic,University of Barcelona,Barcelona,Catalunya,Spain"},{"name":"Institut d'Investigacions Biom\u00e8diques August\u2010Pi\u2010Sunyer (IDIBAPS),University of Barcelona,Barcelona,Catalonia,Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),University of Barcelona,Barcelona,Catalonia,Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Cl\u00ednic,University of Barcelona,Barcelona,Catalunya,Spain"},{"name":"Institut d'Investigacions Biom\u00e8diques August\u2010Pi\u2010Sunyer (IDIBAPS),University of Barcelona,Barcelona,Catalonia,Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),University of Barcelona,Barcelona,Catalonia,Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miquel","family":"Navasa","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Cl\u00ednic,University of Barcelona,Barcelona,Catalunya,Spain"},{"name":"Institut d'Investigacions Biom\u00e8diques August\u2010Pi\u2010Sunyer (IDIBAPS),University of Barcelona,Barcelona,Catalonia,Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),University of Barcelona,Barcelona,Catalonia,Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Arroyo","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Cl\u00ednic,University of Barcelona,Barcelona,Catalunya,Spain"},{"name":"Institut d'Investigacions Biom\u00e8diques August\u2010Pi\u2010Sunyer (IDIBAPS),University of Barcelona,Barcelona,Catalonia,Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),University of Barcelona,Barcelona,Catalonia,Spain"},{"name":"Instituto Reina Sof\u00eda de Investigaci\u00f3n Nefrol\u00f3gica (IRSIN)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pere","family":"Gin\u00e8s","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Cl\u00ednic,University of Barcelona,Barcelona,Catalunya,Spain"},{"name":"Institut d'Investigacions Biom\u00e8diques August\u2010Pi\u2010Sunyer (IDIBAPS),University of Barcelona,Barcelona,Catalonia,Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),University of Barcelona,Barcelona,Catalonia,Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2015,10,26]]},"reference":[{"key":"lt24210-bib-0001-20240115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hep.21094","article-title":"The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond","volume":"43","year":"2006","journal-title":"Hepatology"},{"key":"lt24210-bib-0002-20240115","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome","volume":"362","year":"2003","journal-title":"Lancet"},{"issue":"suppl 1","key":"lt24210-bib-0003-20240115","first-page":"S93","article-title":"Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis","volume":"48","year":"2008","journal-title":"J Hepatol"},{"key":"lt24210-bib-0004-20240115","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","year":"2009","journal-title":"N Engl J Med"},{"key":"lt24210-bib-0005-20240115","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club","volume":"23","year":"1996","journal-title":"Hepatology"},{"key":"lt24210-bib-0006-20240115","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation","volume":"41","year":"2005","journal-title":"Hepatology"},{"key":"lt24210-bib-0007-20240115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-2008-1040323","article-title":"Pathogenesis and treatment of hepatorenal syndrome","volume":"28","year":"2008","journal-title":"Semin Liver Dis"},{"key":"lt24210-bib-0008-20240115","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","year":"2008","journal-title":"Gastroenterology"},{"key":"lt24210-bib-0009-20240115","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A randomized, prospective, double\u2010blind, placebo\u2010controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","year":"2008","journal-title":"Gastroenterology"},{"key":"lt24210-bib-0010-20240115","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s10620-007-9919-9","article-title":"Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome","volume":"53","year":"2008","journal-title":"Dig Dis Sci"},{"key":"lt24210-bib-0011-20240115","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/hep.21901","article-title":"Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome","volume":"46","year":"2007","journal-title":"Hepatology"},{"key":"lt24210-bib-0012-20240115","first-page":"CD005162","article-title":"Terlipressin for hepatorenal syndrome","volume":"9","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"lt24210-bib-0013-20240115","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","year":"2010","journal-title":"J Hepatol"},{"key":"lt24210-bib-0014-20240115","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/ajg.2009.191","article-title":"Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program","volume":"104","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"lt24210-bib-0015-20240115","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/lt.22395","article-title":"Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1","volume":"17","year":"2011","journal-title":"Liver Transpl"},{"key":"lt24210-bib-0016-20240115","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/00042737-200212000-00013","article-title":"Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2","volume":"14","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"lt24210-bib-0017-20240115","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","year":"2007","journal-title":"J Hepatol"},{"key":"lt24210-bib-0018-20240115","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/liv.12179","article-title":"Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study","volume":"33","year":"2013","journal-title":"Liver Int"},{"key":"lt24210-bib-0019-20240115","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/jhep.2003.50315","article-title":"The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club","volume":"38","year":"2003","journal-title":"Hepatology"},{"key":"lt24210-bib-0020-20240115","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/gut.2009.179937","article-title":"Management of patients with cirrhosis awaiting liver transplantation","volume":"60","year":"2011","journal-title":"Gut"},{"key":"lt24210-bib-0021-20240115","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","year":"2007","journal-title":"Gut"},{"key":"lt24210-bib-0022-20240115","first-page":"19","article-title":"Clinical Practice Guideline for Acute Kidney Injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl (2011)"},{"key":"lt24210-bib-0023-20240115","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/gut.2010.236133","article-title":"Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis","volume":"60","year":"2011","journal-title":"Gut"},{"key":"lt24210-bib-0024-20240115","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.gastro.2010.07.043","article-title":"Prognostic importance of the cause of renal failure in patients with cirrhosis","volume":"140","year":"2011","journal-title":"Gastrotenterology"},{"key":"lt24210-bib-0025-20240115","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/TP.0000000000000557","article-title":"Pretransplant type 2 hepatorenal syndrome is associated with persistently impaired renal function after liver transplantation","volume":"99","year":"2015","journal-title":"Transplantation"},{"key":"lt24210-bib-0026-20240115","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jhep.2011.03.012","article-title":"Diagnosis, treatment and survival of patients with hepatorenal syndrome: a survey on daily medical practice","volume":"55","year":"2011","journal-title":"J Hepatol"},{"key":"lt24210-bib-0027-20240115","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/hep.24519","article-title":"Terlipressin: an asset for hepatologists!","volume":"54","year":"2011","journal-title":"Hepatology"},{"key":"lt24210-bib-0028-20240115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","article-title":"Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome","volume":"33","year":"2000","journal-title":"J Hepatol"},{"issue":"pt 1","key":"lt24210-bib-0029-20240115","first-page":"941","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","year":"2002","journal-title":"Hepatology"},{"key":"lt24210-bib-0030-20240115","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/MEG.0b013e3283345524","article-title":"Terlipressin therapy for renal failure in cirrhosis","volume":"22","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"lt24210-bib-0031-20240115","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jhep.2012.06.024","article-title":"Hepatorenal syndrome, MELD score and liver transplantation: an evolving issue with relevant implications for clinical practice","volume":"57","year":"2012","journal-title":"J Hepatol"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.24210","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.24210","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-201511000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T01:23:46Z","timestamp":1705281826000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-201511000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,26]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.24210","relation":{},"ISSN":["1527-6465","1527-6473"],"issn-type":[{"value":"1527-6465","type":"print"},{"value":"1527-6473","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,26]]}}}